Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Import Safety Pilot Casts Global Net For Inspecting Drug Manufacturers

This article was originally published in The Tan Sheet

Executive Summary

The U.S. is launching a pilot program with Australia and the European Union to "spread our inspection net wider" for drug manufacturing facilities, according to Health and Human Services Secretary Michael Leavitt
Advertisement

Related Content

Obama Budget Links Proposed User Fees To Improving Food Safety
Pilot Takes Off For Inspecting API Manufacturers By U.S., Europe, Australia
FDA pilot fishes for import safety answers
FDA, OTC Industry Look To Protect Supply Chain Security From Global Threats
Threat Of Adulteration For Profit Grows With Globalization Of Supply Chain
Threat Of Mandatory Recall A Deterrent, GAO Says In Food Safety Study
Import Safety Summit Has Room At The Table For Many Stakeholders
Import Safety Summit Has Room At The Table For Many Stakeholders
FDA Right On Risk Approach, Slow On Food Protection Progress – GAO
Mandatory Food Recall Power For FDA Better Than Using Existing Authorities?

Topics

Advertisement
UsernamePublicRestriction

Register

PS101868

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel